Literature DB >> 9662761

Risk factors for incident and recurrent condylomata acuminata among women. A population-based study.

L A Habel1, S K Van Den Eeden, K J Sherman, B McKnight, A Stergachis, J R Daling.   

Abstract

BACKGROUND: Condylomata acuminata is one of the most common sexually transmitted diseases (STDs) diagnosed in the United States, yet relatively little research has been conducted on the determinants of this disease in well-defined populations. GOAL: To determine the exposures that predispose a woman to the development of condylomata acuminata or genital warts. STUDY
DESIGN: A population-based case-control study was conducted among enrollees of Group Health Cooperative of Puget Sound. Patients (94 women with incident and 55 women with recurrent condyloma) were diagnosed between April 1, 1987 and September 30, 1991. Control subjects were 133 women without a history of genital warts. An in-person interview was conducted to collect information on subject characteristics, exposures, and on all episodes of genital warts.
RESULTS: Women with five or more partners within the 5 years before reference date were over seven times more likely to have incident condyloma (relative risk [RR], 7.5; 95% confidence interval [CI], 3.1-18.1) and over 12 times more likely to have recurrent condyloma (RR, 12.8; 95% CI, 4.2-38.9) compared with women with only one sexual partner during this time period. An increased risk of incident condyloma was also associated with a history of any STD (RR, 2.6; 95% CI, 1.1-5.8), a history of oral herpes (RR, 2.2; 95% CI, 1.1-4.4), and a history of allergies (RR, 2.0 95% CI, 1.0-3.8). Our data did not support a strong association between risk of condyloma and smoking or recent use of oral contraceptives.
CONCLUSION: Our results suggest that risk of condyloma is primarily related to sexual behavior. We did not observe a strong association between risk of condyloma and many of the exposures considered to be potential cofactors for anogenital cancers associated with other types of human papillomaviruses.

Entities:  

Mesh:

Year:  1998        PMID: 9662761     DOI: 10.1097/00007435-199807000-00003

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  7 in total

1.  HPV vaccine and adolescent males.

Authors:  Paul L Reiter; Annie-Laurie McRee; Jessica A Kadis; Noel T Brewer
Journal:  Vaccine       Date:  2011-06-23       Impact factor: 3.641

2.  HPV vaccine for adolescent males: acceptability to parents post-vaccine licensure.

Authors:  Paul L Reiter; Annie-Laurie McRee; Sami L Gottlieb; Noel T Brewer
Journal:  Vaccine       Date:  2010-07-15       Impact factor: 3.641

3.  Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men.

Authors:  Paul L Reiter; Noel T Brewer; Jennifer S Smith
Journal:  Sex Transm Infect       Date:  2009-11-30       Impact factor: 3.519

Review 4.  The impact of smoking on HPV infection and the development of anogenital warts.

Authors:  Reto Kaderli; Beat Schnüriger; Lukas E Brügger
Journal:  Int J Colorectal Dis       Date:  2014-06-17       Impact factor: 2.571

5.  Demographic and behavioral characteristics of non-sex worker females attending sexually transmitted disease clinics in Japan: a nationwide case-control study.

Authors:  Masako Ono-Kihara; Tatsuya Sato; Hideko Kato; Sonia P Suguimoto-Watanabe; Saman Zamani; Masahiro Kihara
Journal:  BMC Public Health       Date:  2010-03-01       Impact factor: 3.295

6.  Association of immune status with recurrent anal condylomata in human immunodeficiency virus-positive patients.

Authors:  Ji Hyun Sung; Eun Jung Ahn; Heung-Kwon Oh; Sei Hyeog Park
Journal:  J Korean Soc Coloproctol       Date:  2012-12-31

Review 7.  Female genital warts: global trends and treatments.

Authors:  S A Gall
Journal:  Infect Dis Obstet Gynecol       Date:  2001
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.